5-Methylethylone
Names
Preferred IUPAC name
2-(Ethylamino)-1-(7-methyl-2H-1,3-benzodioxol-5-yl)ethan-1-one
Other names
R-MMC; 3,4-Methylenedioxy-5-methyl-N-ethyl cathinone; 5-Methyl-βk-MDEA
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C13H17NO3/c1-4-14-9(3)12(15)10-5-8(2)13-11(6-10)16-7-17-13/h5-6,9,14H,4,7H2,1-3H3
    Key: YCLKQJDSTUZDKJ-UHFFFAOYSA-N
  • CC1=CC(C(C(C)NCC)=O)=CC2=C1OCO2
Properties
C13H17NO3
Molar mass 235.283 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

5-Methylethylone (5-methyl-βk-MDEA, 5ME) is an empathogen, stimulant and psychedelic drug of the amphetamine, phenethylamine, and cathinone chemical classes.[1] It is structurally related to ethylone, a novel designer drug. Relatively little data exists about the pharmacological properties, metabolism, and toxicity of 5-methylethylone, though it has been sold as a designer drug.[2][3]

United States

5-Methylethylone is unscheduled in the United States, but it is not currently approved by the Food and Drug Administration for human consumption. The state of Vermont lists it as a regulated drug.[4]

See also

References

  1. ↑ "3,4-Methylenedioxy-5-methylethcathinone (hydrochloride)]". Cayman Chemical.
  2. ↑ Assi S, Gulyamova N, Kneller P, Osselton D (May 2017). "The effects and toxicity of cathinones from the users' perspectives: A qualitative study". Human Psychopharmacology. 32 (3): e2610. doi:10.1002/hup.2610. PMID 28631397.
  3. ↑ Schifano F, Napoletano F, Arillotta D, Zangani C, Gilgar L, Guirguis A, et al. (March 2020). "The clinical challenges of synthetic cathinones". British Journal of Clinical Pharmacology. 86 (3): 410–419. doi:10.1111/bcp.14132. hdl:2299/21881. PMC 7080616. PMID 31674690.
  4. ↑ Regulated Drugs Rule, Vermont Health Regulations


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.